The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer

Radiotherapy (RT) is a common treatment for localised prostate cancer, but can cause important side effects. The therapeutic efficacy of RT can be enhanced by pharmacological compounds that target specific pathways involved in cell survival. This would elicit a similar therapeutic response using low...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Diaz, R, Nguewa, P A, Diaz-Gonzalez, J A, Hamel, E, Gonzalez-Moreno, O, Catena, R, Serrano, D, Redrado, M, Sherris, D, Calvo, A
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2009
Teme:
Translational Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2661786/
https://ncbi.nlm.nih.gov/pubmed/19240717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604938
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki